T

Telemedi

White-label telemedicine platform for insurers

Senior Product Engineer

Full-TimeUpdated on 10/15/2026
No salary listed
Senior
Warsaw, Poland
Hybrid
Software EngineeringMobile Engineering

About the job

Requirements
  • Solid engineering fundamentals, including programming principles, design patterns such as SOLID, DRY, and KISS, and basic system design.
  • Practical experience with React Native in a production application and strong foundations in React and TypeScript sufficient to contribute to web frontend development.
  • Knowledge of working with databases.
  • Comfort making data-driven decisions, including basic product analytics and reading metrics.
  • Demonstrated ownership, including independently leading features from start to finish rather than only implementing prepared tickets.
  • Fluent Polish.
Responsibilities
  • Develop the React Native mobile application, including new features, refactoring, and bug fixing.
  • Support the web team in JavaScript and PHP when priorities require it.
  • Participate in designing solutions from a product perspective, considering whether and why to build them as well as how.
  • Analyze product data and metrics and derive insights that influence the roadmap.
  • Conduct code reviews and maintain code quality and maintainability.
  • Work closely with QA and the developer team.
Desired Qualifications
  • Experience with native mobile development using Swift or Kotlin in addition to React Native.
  • Familiarity with Symfony or PHP sufficient to read and understand the backend APIs integrated with the application.
  • Experience with large-scale B2C products.
  • Knowledge of GraphQL.

About the company

Telemedi provides a digital health platform for telemedicine, offering online consultations, e-prescriptions, and sick leave documents to patients. It serves insurance and travel-assistance clients, enabling their customers to access doctors across multiple specializations from anywhere and in eight languages. The platform can be delivered as a white-label solution, so partners can integrate Telemedi’s capabilities into their own platforms. Its goal is to help insurers and travel-assistance providers offer reliable, multilingual remote medical care to customers worldwide under their own brand.

Company Size

51-200

Company Stage

Series A

Total Funding

$7.1M

Headquarters

Warsaw, Poland

Founded

2014

Get referred to Telemedi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • UNIQA said in 2024 Telemedi processes around 70,000 medical enquiries monthly.
  • Mavie rolled Telemedi into Austria, Serbia, Montenegro, Croatia, and Bosnia in 2024.
  • Telemedi is hiring AI and GTM engineers in 2026, signaling active product expansion.

What critics are saying

  • Telemedi depends on Mavie for strategy; control shifts away from founder Pawel Sieczkiewicz.
  • Telemedicine reimbursement rules remain political; any Poland or Austria restriction hits bookings immediately.
  • Insurers can switch vendors quickly, and white-label commoditization crushes pricing by 2027.

What makes Telemedi unique

  • Telemedi’s B2B white-label model embeds telemedicine into insurers and assistance platforms.
  • Mavie’s 2023 majority stake gave Telemedi distribution into Austria and CEE.
  • Telemedi offers 24/7 multilingual consultations, prescriptions, and sick leave across several countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-5%

1 year growth

-5%

2 year growth

-5%
Flashpoint
Dec 14th, 2023
Flashpoint announced its 4th exit in 2023, bringing to a total number of 17. The latest exits yielded returns ranging from 30% to 40%. - Flashpoint

Warsaw, 14th December 2023 – Telemedi, leading Polish hybrid healthcare provider and digital health platform, partners with Mavie, an Austrian-based healthcare investor and venture builder. As a long-term partner, Mavie acquires a majority stake in Telemedi and will provide future strategic support to the leading Polish healthtech provider. The two companies plan to work together